MPV as a Predictor for ACS in Patients With MASLD

Inclusion Criteria: * Adult patients aged ≥18 years. * Confirmed diagnosis of metabolic dysfunction-associated steatotic liver disease (MASLD) based on clinical, laboratory, and imaging criteria). * Patients diagnosed with acute coronary syndrome (unstable angina, NSTEMI, or STEMI) for Group I. * MASLD patients without clinical or electrocardiographic evidence of acute coronary syndrome for Group II. * Patients who provide informed consent to participate in the study. Exclusion Criteria: * Patients with chronic liver diseases other than MASLD (e.g., viral hepatitis, autoimmune hepatitis, alcoholic liver disease). * Patients with known hematological disorders affecting platelet count or function. * Patients receiving antiplatelet or anticoagulant therapy prior to blood sampling. * Patients with active infection, inflammatory diseases, or malignancy. * Patients with chronic kidney disease or end-stage renal failure. * Pregnant or lactating females.